Case Control Study to Identify Modifiable Risk Factors for Colorectal and Breast Cancer in Nigeria
- Conditions
- Colorectal CancerBreast Cancer
- Interventions
- Behavioral: QuestionnaireDevice: Bioimpedance/Body Composition Unit
- Registration Number
- NCT05044689
- Lead Sponsor
- Obafemi Awolowo University Teaching Hospital
- Brief Summary
This project is a case-control study which seeks to identify modifiable risk factors for breast and colorectal cancer in Nigeria. Both cases and controls will be required to complete a risk factor questionnaire which contains information about their diet, physical activity, past medical history and life style factors. They will also be required to provide information on their body composition through the use of a bioimpedance machine which measures the body mass index, fat and total body water percentage.
Based on the existing ARGO platform where a current colorectal cancer study is going on, approximately 400 patients with a prior diagnosis or a new diagnosis will be recruited into this study. Comparatively, we will select our 400 controls from two groups of participants who are free of cancer and gastrointestinal diseases.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 800
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Colorectal Cancer (Cases) Questionnaire Based on the existing ARGO (African Colorectal Cancer Group) platform where a current colorectal cancer study is going on, 400 patients with a prior diagnosis and a new diagnosis will be recruited into this study. Colorectal Cancer (Cases) Bioimpedance/Body Composition Unit Based on the existing ARGO (African Colorectal Cancer Group) platform where a current colorectal cancer study is going on, 400 patients with a prior diagnosis and a new diagnosis will be recruited into this study. Controls Questionnaire We will select our 400 controls from two groups of participants who are free of cancer and gastrointestinal diseases. First, we will leverage community mobilization groups to identify and recruit a target group of 200 community-based population controls. Second, we will identify and recruit the remaining 200 controls from those seeking care in the Outpatient Health Center at OAU, which sees \~50-60 patients per day as part of routine care. Controls Bioimpedance/Body Composition Unit We will select our 400 controls from two groups of participants who are free of cancer and gastrointestinal diseases. First, we will leverage community mobilization groups to identify and recruit a target group of 200 community-based population controls. Second, we will identify and recruit the remaining 200 controls from those seeking care in the Outpatient Health Center at OAU, which sees \~50-60 patients per day as part of routine care.
- Primary Outcome Measures
Name Time Method Development and Validation of Questionnaire For Assessing Modifiable Risk Factors for Cancer in Sub-Saharan Africa 2 years Determination of Novel Modifiable Cancer Risk Factors in a Nigerian Population 2 years We will determine the presence of established, plausible, and novel cancer risk factors in cases (n=400) and controls (n=400) in Nigeria
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Obafemi Awolowo University Teaching Hospitals
🇳🇬Ile Ife, Osun, Nigeria